The innovation offers potential advancements in diagnosing conditions like arrhythmia and Alzheimer’s.

Researchers at MIT have unveiled a biosensing technique that uses tiny, wireless antennas to monitor electrical signals in biological systems with unprecedented precision.

By eliminating the need for wires and amplifiers, the innovation simplifies cellular studies, offering potential advancements in diagnosing conditions like arrhythmia and Alzheimer’s and enabling more targeted treatments.

Electrical signals are fundamental to cellular communication, yet traditional methods for measuring them are cumbersome and limited in scope.

A groundbreaking clinical trial has revealed that nerve-stimulating therapy can bring significant improvements to people with severe, treatment-resistant depression.

Nearly 500 participants, many unable to work due to their condition, received devices that stimulate the vagus nerve—a critical connection between the brain and body. After a year, those with activated devices reported measurable improvements in symptoms, quality of life, and daily functioning.

Breakthrough in Treatment-Resistant Depression.

A device that delivers a small electrical current to the brain has beneficial effects in cases of depression that doesn’t respond to drugs or therapy.

There’s still so much we don’t know about Alzheimer’s disease, but the link between poor sleep and worsening disease is one that researchers are exploring with gusto.

In a study published in 2023, scientists found that using sleeping pills to get some shut-eye could reduce the build-up of toxic clumps of proteins in fluid that washes the brain clean every night.

Researchers from Washington University in St. Louis found people who took suvorexant, a common treatment for insomnia, for two nights at a sleep clinic experienced a slight drop in two proteins, amyloid-beta and tau, that pile up in Alzheimer’s disease.